Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the felgehiwot referral hospital, Ethiopia

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Abera, Bayeh ^a   Zenebe, Yohanes ^a   Mulu, Wondemagegn ^a   Kibret, Mulugeta ^a   Kahsu, Getachew ^b  

^a BAHIR DAR UNIVERSITY   (Ethiopia)

^b Bahir Dar Regional Health Research Laboratory Center   (Ethiopia)

Author keywords

ALT; Children; HBV; HCV; HIV

Indexed keywords

ALANINE AMINOTRANSFERASE;

BLOOD; CHILD; COINFECTION; COMPLICATION; DEMOGRAPHY; ETHIOPIA; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HUMAN; IMMUNOLOGY; MALE; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; RISK FACTOR; STATISTICAL MODEL;

ALANINE TRANSAMINASE; CHILD; COINFECTION; DEMOGRAPHY; ETHIOPIA; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; REFERRAL AND CONSULTATION; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84964312568     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-838     Document Type: Article

References (32)

1. Matthews CP, Geretti AM, GoulderP JR, Klenerman P: Epidemiology of and impact of HIV coinfection with hepatitis B andHepatitis C viruses in Sub-Saharan Africa. J Clin Virol 2014, 61:20-33.
2. Federal Ministry of Health (FMOH): Country Progress Report on HIV/AIDS Response. Addis Ababa, Ethiopia: National HIV/AIDS Prevention and Control Office; 2012.
3. Alter MJ: Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006, 44:S6-S9.
4. Chu CJ, Lee SD: Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 2008, 23:512-520.
5. Barth RE, Huijgen Q, Taljaard J, Hoepelman AI: Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis 2010, 14:e1024-e1031.
6. Dessie A, Abera B, Wale F: Seroprevalence of major blood-borne infections among blood donors at Felege Hiwot referral hospital, northwest Ethiopia. Ethiop J Health Dev 2007, 21:68-69.
7. Gelaw B, Mengistu Y: Prevalence of HBV, HCV and malaria parasites among blood donors in Amhara and Tigray regional states. Ethiop J Health Dev 2007, 22:3-7.
8. Gunn RA, Murray PJ, Ackers ML, Hardison WG, Margolis HS: Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic-rationale for integrating services. Sex Transm Dis 2001, 28:166-170.
9. Andreoni M, Giacometti A, Maida I, Meraviglia P, Ripamonti D, Sarmati L: HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. Eur Rev Med Pharmacol Sci 2012, 16:1473-1483.
10. Tien PC: Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the veterans affairs hepatitis C resource cemter program and national hepatitis C program office. Am J Gastroenterol 2005, 100:2338-2354.
11. World Health Organization (WHO): Hepatitis C. Geneva: WHO; 2003.
12. Tsuchiya N, Pathipvanich P, Rojanawiwat A, Wichukchinda N, Koga I, Koga M, Auwanit W, Kilgore PE, Ariyoshi K, Sawanpanyalert P: Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in northern Thailand. Epidemiol Infect 2012. 10.1017/S0950268812002397 Cambridge University Press 2012.
13. World Health Organization (WHO): Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. Geneva: WHO; 2010:1-63.
14. Zenebe H, Mulu W, Yimer M, Abera B: Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis 2014, 14:118-125.
15. Federal Ministry of Health (FMO): Guidelines for Paediatric HIV/AIDS Care and Treatment in Ethiopia. Ethiopia: Federal HIV/AIDS Prevention and Control Office Federal Ministry of Health; 2008.
16. Assefa Y, Kiflie A, Tesfaye D, Hailemariam D, Kloos H, Edwin W, Laga M, Damme WV: Outcomes of antiretroviral treatment program in Ethiopia: retention of patients in care is a major challenge and varies across health facilities. BMC Health Serv Res 2011, 11:81-88.
17. Katabuka M, Mafuta ME, Ngoma AM, Beya PM, Yuma S, Aketi L, Kayembe K, Gini JR: Prevalence and risk factors for hepatitis C virus, hepatitis B virus and immunodeficiency virus in transfused children in Kinshasa. Indian J Pediatr 2013, 80:659-662.
18. Telatela SP, Matee MI, Munubhi EK: Seroprevalence of hepatitis B and C viral co-infections among children infected withhuman immunodeficiency virus attending the paediatric HIV care and treatment centerat Muhimbili National Hospital in Dar-es Salaam, Tanzania. BMC Public Health 2007, 7:338. doi:10.1186/1471-2458-7-338.
19. Nwolisa E, Mbanefo F, Ezeogu J, Amadi P: Prevalence of hepatitis B co-infection amongst HIV infected children attending a care and treatment centre in Owerri, South-eastern Nigeria. Pan Afr Med J 2013, 14:89.
20. Anigilaje EA, Olutola A: Prevalence and clinical and immunovirological profile of human immunodeficiency virus-hepatitis B coinfection among children in an antirethroviral therapy prohramme in Benue State, Nigeria. ISRN Pediatr 2013, 2013: doi.org/10.1155/2013/932697.
21. Ikpeme EE, Etukudo O, Ekrikpo UE: Seroprevalence of HBV and HIV co-infection in children and outcomes following highly active antirethroviral therapy (HAART) in Uyo, South-south Nigeria. Afr Health Sci 2013, 13:955-961.
22. Jobarteh M, Malfroy M, Peterson I, Jeng A, Sarge-Njie R, Alabi A, Peterson K, Cotton M, Hall A, Jones SR, Whittle H, Tedder R, Jaye A, Mendy M: Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Virol J 2010, 7:230.
23. Mulu W, Gidey B, Chernet A, Alem G, Abera B: Hepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at FelegHiwot referral hospital, Bahir Dar Ethiopia. Ethiop J Health Sci 2013, 23:217-226.
24. Tramuto F, Maida CM, Colomba GME, Carlo PD, Vitale F: Prevalence of occult hepatitis B virus infection in a cohort of HIV-positive patients resident in Sicily, Italy. Biomed Res Int 2013 2013. doi.org/10.1155/2013/859583.
25. Toussi SS, Abadi J, Rosenberg M, Levanon D: Prevalence of hepatitis B and C virus infections in children infected with HIV. HIV/AIDS 2007, 45:795-798.
26. Karoney MJ, Siika AM: Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J 2013, 14:44. doi:10.11604.
27. Eze JC, Ibeziako NS, Ikefuna AN, Nwokye IC, Uleanya ND, Iiechukwu GC: Prevalence and risk factors for hepatitis C and human immunodeficiency virus coinfection among children in Enugu Nigeria. Afr J Infect Dis 2014, 8:5-8.
28. Ayele W, Nokes DJ, Abebe A, Messele T, Dejene A, Enquselassie F, Rinke de Wit TF, Fontanet AL: Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia. J Med Virol 2002, 68:12-17.
29. Hadush H, Gebre-Selassie S, Mihret A: Hepatitis C virus and human immunodeficiency virus coinfection among attendants of voluntary counseling and testing centre and HIV follow up clinics in Mekelle Hospital. Pan Afr Med J 2013, 14:107. doi:10.11604/pamj.2013.14.107.
30. Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA: Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes 2013, 6:363.
31. UNICEF: Policy Brief: Abandoning FGM/C (Female Genital Mutilation/Cutting) in Ethiopia. UNICEF: Ethiopia; 2013.
32. Hoffmann CJ, Charalambous S, Martin DJ, Innes C, Churchyard GJ, Chaisson R, Grant AD, Fielding KL, Thio CL: Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis 2008, 47:1479-1485.